Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
Date:3/5/2009

rges, acquired in-process research and development relating to license agreements and acquisitions, stock-based compensation expense, foreign exchange gains or losses relating to translation of foreign denominated items and other non-recurring items. Adjusted net loss from continuing operations, adjusted net loss per share from continuing operations and Adjusted EBITDA also exclude litigation expenses related to defending intellectual property claims. Revenue, as adjusted, excludes non-recurring, non-operating revenue derived from license agreements and other license revenue, net of license fees due to licensors and excludes amounts accrued for costs incurred. Adjusted net loss from continuing operations, adjusted net loss per share from continuing operations, revenue, as adjusted, and Adjusted EBITDA do not have any standardized meaning prescribed by GAAP and therefore may not be comparable to similar measures presented by other issuers. Management uses these non-GAAP or adjusted operating measures to establish operational goals and believes that these measures may assist investors in evaluating the results of the business and analyzing the underlying trends in our business over time. Investors should consider these non-GAAP measures in addition to, not as a substitute for, or as superior to, financial reporting measures prepared in accordance with GAAP. We have provided a reconciliation of these measures to GAAP in the attached tables.

    Conference Call Information
    ----------------------------
    A conference call to discuss these financial results will be held today,
Thursday March 5, 2009 at 7:00 AM PT (10:00 AM ET).

    Dial-in information:
    North America (toll-free): (800) 291-9234
    International: (617) 614-3923
    Enter passcode: 52474180

    A replay archive of the conference call will be available until March 12,
2009 by calling (888) 286-8010 (in North America) or (617) 801-6888
(International) and entering 
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
2. Angiotech Pharmaceuticals announces time change of conference call and webcast
3. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
4. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
5. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
6. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
7. Angiotech wins before the UK House of Lords
8. Angiotech to Establish Separate Operating and Royalty Businesses
9. Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
10. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
11. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 30, 2014 The evening of ... decades-long heritage in successful medical device development to ... what it takes to successfully innovate in the ... of a two-hour on-site class, Insight gave master’s ... business, McCormick School of Engineering, medical and law ...
(Date:10/31/2014)... October 31, 2014 The report ... Rice), Formulation (Plain, Flavored, Sweetened, Unsweetened), Channel (Supermarket, ... Global Trends & Forecast to 2018," defines and ... analysis and forecast of revenue and volume for ... is projected to reach $14 Billion by 2018 ...
(Date:10/31/2014)... Oct. 31, 2014  Atlanta-based Intellimedix could make ... the onset of Ebola by suggesting a new, ... Georgia Tech,s Center for Computational Systems Biology have ... find alternative uses for existing drugs through systematic ... aid the bout against Ebola. ...
(Date:10/30/2014)... 30, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Naltrexone HCL information, including its definition, classification, application, ... overview. This research covers the international market analysis, ... industry analysis covering macroeconomic environment & economic situation ...
Breaking Biology Technology:Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3
... National Business Group on Health Names Leading Companies that Promote a ... ... The National Business,Group on Health (NBGH), a national non-profit organization of ... and promoting a healthy lifestyle for employees and their,families., GSK ...
... with Improved Usability & ... ... high incidence,of women,s health conditions that require intra-vaginal drug delivery and,the ... an alarming majority of women find their current treatment,options "unacceptable" or ...
... Germany, May 13 Caviar has become one ... view of the over fished,sturgeon populations in the ... sustainable aquaculture. United Food Technologies AG (UFT) has ... know-how in this sector.,This week, the company delivered ...
Cached Biology Technology:GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles 2GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles 3GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles 472% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds 2Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant 2
(Date:10/29/2014)... air pollutants released by unconventional oil and gas production ... published today in the open access journal Environmental ... formaldehyde were found. The study is the first to ... near production sites and could be used to supplement ... come from reserves that do not readily flow to ...
(Date:10/29/2014)... largest study of its kind to date, researchers have ... heighten the risk for autism. Joseph Buxbaum, Ph.D., Icahn ... Mark Daly, Ph.D., Broad Institute of Harvard and MIT, ... from affected children, parents and unrelated people. They identified ... to the risk for autism spectrum disorder (ASD) – ...
(Date:10/29/2014)... open for the Society of Interventional Radiology,s ... is the one place where interventional radiologists, ... care professionals can come together to find ... being presented, discussed and tested. , ... image-guided medicine, SIR 2015 will feature essential ...
Breaking Biology News(10 mins):Air quality and unconventional oil and gas sites 2Air quality and unconventional oil and gas sites 3SIR 2015: Interventional radiology shapes tomorrow's medicine 2
... the time, the immune system is the body,s protector, warding ... infection and disease. But in autoimmune diseases, the immune ... attacking normal cells. A major discovery by La Jolla ... previously unknown molecular interaction that is essential for T lymphocyte ...
... team of Russian veterinary colleagues and health experts from the ... distemper -- a virus afflicting domestic dogs and many wildlife ... tigers. The team presented its results at the first-ever ... Russian Far East city of Ussurisk. The symposium underscores ...
... stem cell therapies will be among the research topics ... on Cardiovascular Regenerative Medicine, which will be held Oct. ... into the state of the regenerative medicine field. ... Lung, and Blood Institute and the Foundation for the ...
Cached Biology News:La Jolla Institute discovers previously unknown cell interaction key in immune system attacks 2La Jolla Institute discovers previously unknown cell interaction key in immune system attacks 3Russian and US veterinarians collaborate to solve mysterious wild tiger deaths 2Russian and US veterinarians collaborate to solve mysterious wild tiger deaths 3NIH hosts Cardiovascular Regenerative Medicine Symposium Oct. 4-5 2
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
...
... several important steps of angiogenesis including proliferation, migration, ... reduces intracellular reactive oxygen species (ROS) level, H(2)O(2)-dependent ... Formula: ... MolWeight: 360.31484 Store ...
Biology Products: